Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Eurofins to expand its presence in North America with the acquisition of EAG Laboratories

Tuesday, September 19, 2017

Eurofins Scientific a global leader in bioanalytical testing announces that it has signed an agreement to acquire EAG Laboratories EAG a leading global scientific services company providing analytical testing and consulting solutions to a diverse and demanding set of end markets from Odyssey Investm..

TSI Completes Phase 1 Clinical Trial of Novel Clot-dissolving Therapy, TS01

Tuesday, September 19, 2017

Thrombolytic Science LLC TSI a clinical stage vascular health and biotechnology company today announced the completion of a Phase 1 clinical trial of TS01 a newgeneration clotdissolving therapy aimed at the treatment of clotinduced diseases such as ischemic stroke and acute myocardial infarction or ..

China's Fosun Pharma to buy smaller stake in Indian pharma firm

Monday, September 18, 2017

Shanghai Fosun Pharmaceutical Group has agreed to cut the size of the stake it will buy in Indias Gland Pharma to 74 percent the Chinese drugmaker said on Sunday It said Gland Pharmas founding family wanted to retain a higher stake in the Indian firm because of its good performance Fosun had p..

Regeneron and Sanofi Announce Positive Study Results for DUPIXENT®

Monday, September 18, 2017

Regeneron Pharmaceuticals Inc NASDAQ REGN and Sanofi today announced positive results from the Phase 3 CAF study of DUPIXENT dupilumab in adults with moderatetosevere atopic dermatitis AD who are inadequately controlled with or are intolerant to the broad immunosuppressant drug cyclosporine A CSA or..

Boehringer Ingelheim receives positive CHMP opinion for adalimumab biosimilar CYLTEZO®

Saturday, September 16, 2017

Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has adopted a positive opinion for the Marketing Authorisation Application of Cyltezo adalimumab biosimilar to treat multiple chronic inflammatory diseases in adults and c..

CSL Behring Announces FDA Approval of Privigen®

Saturday, September 16, 2017

Global biotherapeutics leader CSL Behring today announced that the US Food and Drug Administration FDA has approved Privigen Immune Globulin Intravenous Human 10 Liquid for the treatment of adults with chronic inflammatory demyelinating polyneuropathy CIDP to improve neuromuscular disability CIDP is..

Bristol-Myers Squibb and Halozyme Enter Global Collaboration and License Agreement

Friday, September 15, 2017

BristolMyers Squibb Company and Halozyme Therapeutics Inc announced a global collaboration and license agreement to develop subcutaneously administered BristolMyers Squibb immunooncology medicines using Halozymes ENHANZE drugdelivery technology We are excited to partner with Halozyme to pursue po..

Ambry Genetics Announces Integration with FDNA to Advance Precision Medicine

Friday, September 15, 2017

Ambry Genetics Corporation announces integration between their secure AmbryPort 20 AP2 clinician ordering platform and FDNAs Face2Gene suite of applications This integration is expected to dramatically increase and transform the diagnostic power of genetic testing in rare diseases Driven to give ..

Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay

Thursday, September 14, 2017

Agilent Technologies Inc has announced that it has obtained 510k clearance from the US Food and Drug Administration FDA for the GenetiSure Dx Postnatal Assay its first comparative genomic hybridization CGH assay for diagnostic use This assay enables clinical geneticists to detect genetic aberrations..

MilliporeSigma Expands Celonic's Upstream Capabilities with Mobius® Single-use Bioreactors

Thursday, September 14, 2017

MilliporeSigma today announced that Celonic AG a Swiss contract development and manufacturing organization CDMO is upgrading its manufacturing facility with five of MilliporeSigma39s Mobius singleuse bioreactors Celonic which produces biosimilars and also offers a cell line development platform w..

TOP